Expression of cytoadhesion molecules (CD56, CD54, CD18 and CD29) by myeloma plasma cells.
Recently we reported the expression of the human natural killer cell associated antigen CD56 (Leu 19/NKH1) in plasma cells of a majority of multiple myeloma (MM) patients. CD56 is known to be an isoform of the human neural adhesion molecule N-CAM which is involved in homotypic adhesive interactions. By immunophenotyping using four CD56 specific monoclonal antibodies and immunoprecipitation analysis we here confirm that the Leu 19 antigen expressed by myeloma plasma cells is identical to N-CAM and corresponds to the 145 kDa isoform. Because of the possible biological role of adhesion molecules on myeloma cells, we compared the expression of N-CAM with the intercellular adhesion molecule 1 (ICAM-1) and the beta 1 and beta 2 integrins. By immunogold-silver staining of cytospin preparations of mononuclear cell suspensions, bone marrow plasma cells of 17 MM patients were analysed. Plasma cells expressed N-CAM (CD56) in 14 patients. ICAM-1 (CD54) in 16 patients, and beta 2 integrins (CD18) in eight patients. beta 1 integrins (CD29) were expressed in all patients. The expression of beta 2 integrins was always very weak while N-CAM, ICAM-1 and the beta 1 integrins showed a moderate to strong positivity. The plasma cells of five haematological normal individuals lacked significant N-CAM expression but were positive for ICAM-1 and both integrin subgroups. One plasma cell leukaemia patient and two out of four end-stage MM patients showed no expression of N-CAM or beta 2 integrins on their circulating plasma cells. Among 11 previously established myeloma cell lines, surface expression of ICAM-1 and the integrins was detected in most cases, while N-CAM was present in only four lines. Most cell lines showed coexpression of the fibronectin receptors (VLA-4 and VLA-5) and the laminin receptor (VLA-6). The collagen receptor (VLA-2) was not expressed. The N-CAM negative cell lines included four cell lines that were derived from plasma cell leukaemia patients. These results indicate that the expression of adhesion molecules is an intrinsic part of the biology of multiple myeloma.
Van Riet
I
I
Department of Hematology-Immunology, Faculty of Medicine, Free University of Brussels (V.U.B.), Belgium.
De Waele
M
M
Remels
L
L
Lacor
P
P
Schots
R
R
Van Camp
B
B
D015703:Antigens, CD / Q000032:analysis*; D000945:Antigens, Differentiation, T-Lymphocyte / Q000032:analysis; D018821:CD18 Antigens; D019002:CD56 Antigen; D015815:Cell Adhesion Molecules / Q000032:analysis*; D002460:Cell Line; D006801:Humans; D019012:Integrin beta1; D018799:Intercellular Adhesion Molecule-1; D009101:Multiple Myeloma / Q000276:immunology / Q000378:metabolism*; D009363:Neoplasm Proteins / Q000032:analysis*; D011233:Precipitin Tests
D015703:Antigens, CD; D000945:Antigens, Differentiation, T-Lymphocyte; D018821:CD18 Antigens; D019002:CD56 Antigen; D015815:Cell Adhesion Molecules; D019012:Integrin beta1; D009363:Neoplasm Proteins; D018799:Intercellular Adhesion Molecule-1